activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	2470118	CHEMBL1032261	Inhibition of BMPR1B at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL5476	Homo sapiens	INH	%	10.0
	2470118	CHEMBL1032261	Inhibition of BMPR1B at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL5476	Homo sapiens	INH	%	10.0
	2595808	CHEMBL1017878	Inhibition of BMPR1B assessed as enzyme activity relative to control	B	C[C@@H]1CCN(C(=O)CC#N)C[C@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL459977	=	Activity	%	28.0	CHEMBL5476	Homo sapiens	Activity	%	28.0
	2921429	CHEMBL1052191	Inhibition of BMPR1B assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	96.0	CHEMBL5476	Homo sapiens	Activity	%	96.0
	2928463	CHEMBL1049961	Binding affinity to BMPR1B assessed as percentage of kinase remaining bound to the bead at 1 uM by T7 phage display based binding assay	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	0.9	CHEMBL5476	Homo sapiens	Activity	%	0.9
	3331839	CHEMBL1168798	Inhibition of BMPR1B at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL5476	Homo sapiens	INH	%	50.0
	3333254	CHEMBL1168798	Inhibition of BMPR1B at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL5476	Homo sapiens	INH	%	50.0
	3334659	CHEMBL1168798	Inhibition of BMPR1B at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL5476	Homo sapiens	INH	%	50.0
	3336079	CHEMBL1168798	Inhibition of BMPR1B at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL5476	Homo sapiens	INH	%	50.0
	3340607	CHEMBL1168798	Inhibition of BMPR1B at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL5476	Homo sapiens	INH	%	50.0
	3342023	CHEMBL1168798	Inhibition of BMPR1B at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL5476	Homo sapiens	INH	%	50.0
	3358466	CHEMBL1174080	Inhibition of BMPR1B at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	78.0	CHEMBL5476	Homo sapiens	INH	%	78.0
	3358908	CHEMBL1174080	Inhibition of BMPR1B at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	72.0	CHEMBL5476	Homo sapiens	INH	%	72.0
	3445040	CHEMBL1244736	Binding affinity to BMPR1B	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	57.0	CHEMBL5476	Homo sapiens	Kd	nM	57.0
	3448697	CHEMBL1244736	Binding affinity to BMPR1B	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	uM	10.0
	3449572	CHEMBL1244736	Binding affinity to BMPR1B	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	uM	10.0
	3449996	CHEMBL1244736	Binding affinity to BMPR1B	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	uM	10.0
	3450293	CHEMBL1244736	Binding affinity to BMPR1B	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	uM	10.0
	3450922	CHEMBL1244736	Binding affinity to BMPR1B	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	uM	10.0
	3451213	CHEMBL1244736	Binding affinity to BMPR1B	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	uM	10.0
	6341022	CHEMBL1827752	Activity of BMPR1B kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL5476	Homo sapiens	Activity	%	100.0
	7567220	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7567679	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7568150	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7568618	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7569193	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7569653	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	230.0	CHEMBL5476	Homo sapiens	Kd	nM	230.0
	7570125	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Kd	nM	1800.0	CHEMBL5476	Homo sapiens	Kd	nM	1800.0
	7570573	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	2400.0	CHEMBL5476	Homo sapiens	Kd	nM	2400.0
	7571169	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7571626	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	53.0	CHEMBL5476	Homo sapiens	Kd	nM	53.0
	7572123	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7572539	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	0.85	CHEMBL5476	Homo sapiens	Kd	nM	0.85
	7573150	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7573607	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7573641	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	370.0	CHEMBL5476	Homo sapiens	Kd	nM	370.0
	7574110	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7574518	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7575128	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7575618	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	=	Kd	nM	2200.0	CHEMBL5476	Homo sapiens	Kd	nM	2200.0
	7576083	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	=	Kd	nM	3100.0	CHEMBL5476	Homo sapiens	Kd	nM	3100.0
	7576491	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	410.0	CHEMBL5476	Homo sapiens	Kd	nM	410.0
	7577119	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7577597	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	120.0	CHEMBL5476	Homo sapiens	Kd	nM	120.0
	7578067	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	2.1	CHEMBL5476	Homo sapiens	Kd	nM	2.1
	7578472	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	240.0	CHEMBL5476	Homo sapiens	Kd	nM	240.0
	7578668	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7579042	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7579492	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	450.0	CHEMBL5476	Homo sapiens	Kd	nM	450.0
	7579966	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7580435	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7580838	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	1100.0	CHEMBL5476	Homo sapiens	Kd	nM	1100.0
	7581026	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7581411	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7581856	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	=	Kd	nM	1800.0	CHEMBL5476	Homo sapiens	Kd	nM	1800.0
	7582327	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7582791	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	720.0	CHEMBL5476	Homo sapiens	Kd	nM	720.0
	7583191	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7583372	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	710.0	CHEMBL5476	Homo sapiens	Kd	nM	710.0
	7583769	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7584214	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7584685	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7585702	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7586110	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7586556	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7587039	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7587663	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	2900.0	CHEMBL5476	Homo sapiens	Kd	nM	2900.0
	7588082	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	57.0	CHEMBL5476	Homo sapiens	Kd	nM	57.0
	7588535	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7588564	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7589015	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	3300.0	CHEMBL5476	Homo sapiens	Kd	nM	3300.0
	7589628	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7590052	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7590551	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7591002	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7591601	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7592053	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7592526	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7592979	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7593561	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7594033	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7594506	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7594958	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7595094	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7595538	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	2600.0	CHEMBL5476	Homo sapiens	Kd	nM	2600.0
	7596012	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7596483	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	1000.0	CHEMBL5476	Homo sapiens	Kd	nM	1000.0
	7596930	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	170.0	CHEMBL5476	Homo sapiens	Kd	nM	170.0
	7597066	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7597519	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7597992	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL5476	Homo sapiens	Kd	nM	10000.0
	7598462	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	4.0	CHEMBL5476	Homo sapiens	Kd	nM	4.0
	7598904	CHEMBL1908522	Binding constant for BMPR1B kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	3700.0	CHEMBL5476	Homo sapiens	Kd	nM	3700.0
	7982591	CHEMBL1936975	Inhibition of BMPR1B at 10 uM after 1 hr by competitive binding assay	B	CNC(=O)NC[C@H]1O[C@@H](n2cnc3c(NC(=O)Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL1079596	=	Inhibition	%	45.0	CHEMBL5476	Homo sapiens	INH	%	45.0
	7982592	CHEMBL1936975	Inhibition of BMPR1B at 10 uM after 1 hr by competitive binding assay	B	CCOC(=O)C[C@@H]1[C@@H](CNC(=O)NC)O[C@@H](n2cnc3c(NC(=O)Nc4ccccc4)ncnc32)[C@@H]1O[Si](C)(C)C(C)(C)C		CHEMBL1076310	=	Inhibition	%	47.0	CHEMBL5476	Homo sapiens	INH	%	47.0
	7982617	CHEMBL1937144	Binding affinity to BMPR1B by multi dose competitive binding assay	B	CNC(=O)NC[C@H]1O[C@@H](n2cnc3c(NC(=O)Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL1079596	=	Kd	nM	11500.0	CHEMBL5476	Homo sapiens	Kd	uM	11.5
Not Active	7982618	CHEMBL1937145	Binding affinity to BMPR1B at >30 uM by multi dose competitive binding assay	B	CNC(=O)NC[C@H]1O[C@@H](n2cnc3c(NC(=O)Nc4ccccc4)ncnc32)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1O[Si](C)(C)C(C)(C)C		CHEMBL1076332		Activity			CHEMBL5476	Homo sapiens	Activity		
	11022158	CHEMBL2090294	Inhibition of BMPR1b assessed as activity remaining at 10 uM by competitive binding inhibition assay	B	CC[Si](CC)(CC)O[C@@H]1[C@@H](CNC(=O)NC)O[C@@H](n2cnc3c(NC(=O)Nc4ccccc4)ncnc32)[C@@H]1O[Si](CC)(CC)CC		CHEMBL2087362	=	Activity	%	100.0	CHEMBL5476	Homo sapiens	Activity	%	100.0
	11022159	CHEMBL2090294	Inhibition of BMPR1b assessed as activity remaining at 10 uM by competitive binding inhibition assay	B	CNC(=O)NC[C@H]1O[C@@H](n2cnc3c(NC(=O)Nc4ccccc4)ncnc32)[C@H](O[Si](c2ccccc2)(c2ccccc2)C(C)(C)C)[C@@H]1O[Si](c1ccccc1)(c1ccccc1)C(C)(C)C		CHEMBL2087363	=	Activity	%	100.0	CHEMBL5476	Homo sapiens	Activity	%	100.0
	11022160	CHEMBL2090294	Inhibition of BMPR1b assessed as activity remaining at 10 uM by competitive binding inhibition assay	B	CNC(=O)NC[C@H]1O[C@@H](n2cnc3c(NC(=O)Nc4ccccc4)ncnc32)[C@H](O[Si](C(C)C)(C(C)C)C(C)C)[C@@H]1O[Si](C(C)C)(C(C)C)C(C)C		CHEMBL2087364	=	Activity	%	100.0	CHEMBL5476	Homo sapiens	Activity	%	100.0
	11022161	CHEMBL2090294	Inhibition of BMPR1b assessed as activity remaining at 10 uM by competitive binding inhibition assay	B	CNC(=O)NC[C@H]1O[C@@H](n2cnc3c(NC(=O)Nc4ccccc4)ncnc32)[C@H](OC(C)=O)[C@@H]1OC(C)=O		CHEMBL2087365	=	Activity	%	95.0	CHEMBL5476	Homo sapiens	Activity	%	95.0
	11022162	CHEMBL2090294	Inhibition of BMPR1b assessed as activity remaining at 10 uM by competitive binding inhibition assay	B	CNC(=O)NC[C@H]1O[C@@H](n2cnc3c(NC(=O)Nc4ccccc4)ncnc32)[C@H](OC(=O)c2ccccc2)[C@@H]1OC(=O)c1ccccc1		CHEMBL2087366	=	Activity	%	100.0	CHEMBL5476	Homo sapiens	Activity	%	100.0
	11022163	CHEMBL2090294	Inhibition of BMPR1b assessed as activity remaining at 10 uM by competitive binding inhibition assay	B	CNC(=O)NC[C@H]1O[C@@H](n2cnc3c(NC(=O)Nc4ccccc4)ncnc32)[C@H](OC(=O)C(C)C)[C@@H]1OC(=O)C(C)C		CHEMBL2087367	=	Activity	%	100.0	CHEMBL5476	Homo sapiens	Activity	%	100.0
	12060544	CHEMBL2154881	Binding affinity to BMPR1B	B	Nc1nc2c(-c3cnc4ccccc4c3)nccc2[nH]1		CHEMBL2153266	=	Kd	nM	720.0	CHEMBL5476	Homo sapiens	Kd	nM	720.0
	12173726	CHEMBL2212064	Inhibition of BMPR1B assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL5476	Homo sapiens	Activity	%	100.0
	13321785	CHEMBL2390522	Inhibition of ALK6 (unknown origin)	B	CN1CCN(c2ccc(-c3cnc4c(-c5ccnc6ccccc56)cnn4c3)cc2)CC1		CHEMBL2385596	<	IC50	nM	5.0	CHEMBL5476	Homo sapiens	IC50	nM	5.0
	13321786	CHEMBL2390522	Inhibition of ALK6 (unknown origin)	B	c1ccc2c(-c3cnn4cc(-c5ccc(N6CCOCC6)cc5)cnc34)ccnc2c1		CHEMBL2385582	<	IC50	nM	5.0	CHEMBL5476	Homo sapiens	IC50	nM	5.0
	13321804	CHEMBL2390522	Inhibition of ALK6 (unknown origin)	B	COc1ccc(-c2cnc3c(-c4cccc5ncccc45)cnn3c2)cc1		CHEMBL502351	=	IC50	nM	9830.0	CHEMBL5476	Homo sapiens	IC50	nM	9830.0
	13321841	CHEMBL2390522	Inhibition of ALK6 (unknown origin)	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	IC50	nM	235.0	CHEMBL5476	Homo sapiens	IC50	nM	235.0
	13321850	CHEMBL2390522	Inhibition of ALK6 (unknown origin)	B	c1cc(N2CCNCC2)ccc1-c1cnc2c(-c3cn[nH]c3)cnn2c1		CHEMBL2385586	=	IC50	nM	129.0	CHEMBL5476	Homo sapiens	IC50	nM	129.0
	13322749	CHEMBL2390522	Inhibition of ALK6 (unknown origin)	B	COc1ccc(-c2cnc3c(-c4cn[nH]c4)cnn3c2)cc1		CHEMBL2385600	=	IC50	nM	102.0	CHEMBL5476	Homo sapiens	IC50	nM	102.0
	13322752	CHEMBL2390522	Inhibition of ALK6 (unknown origin)	B	c1cc(-c2cnn3cc(-c4ccc(N5CCNCC5)cc4)cnc23)c2cccnc2c1		CHEMBL2385591	=	IC50	nM	92.9	CHEMBL5476	Homo sapiens	IC50	nM	92.9
	13322757	CHEMBL2390522	Inhibition of ALK6 (unknown origin)	B	c1cc(N2CCOCC2)ccc1-c1cnc2c(-c3cn[nH]c3)cnn2c1		CHEMBL2385579	=	IC50	nM	60.9	CHEMBL5476	Homo sapiens	IC50	nM	60.9
	13322758	CHEMBL2390522	Inhibition of ALK6 (unknown origin)	B	c1ccc2c(-c3cnn4cc(-c5ccc(N6CCNCC6)cc5)cnc34)ccnc2c1		CHEMBL513147	=	IC50	nM	60.0	CHEMBL5476	Homo sapiens	IC50	nM	60.0
	13322760	CHEMBL2390522	Inhibition of ALK6 (unknown origin)	B	COc1ccc(-c2cnc3c(-c4ccnc5ccccc45)cnn3c2)cc1		CHEMBL511563	=	IC50	nM	56.9	CHEMBL5476	Homo sapiens	IC50	nM	56.9
	13322765	CHEMBL2390522	Inhibition of ALK6 (unknown origin)	B	CC(C)Oc1ccc(-c2cnc3c(-c4ccnc5ccccc45)cnn3c2)cc1		CHEMBL2385597	=	IC50	nM	47.6	CHEMBL5476	Homo sapiens	IC50	nM	47.6
	14659690	CHEMBL3269164	Inhibition of ALK6 (unknown origin) by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	>	IC50	nM	10000.0	CHEMBL5476	Homo sapiens	IC50	uM	10.0
	14659691	CHEMBL3269164	Inhibition of ALK6 (unknown origin) by radioisotopic assay	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	IC50	nM	467.0	CHEMBL5476	Homo sapiens	IC50	uM	0.467
	15756110	CHEMBL3631724	Inhibition of ALK6 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	92.75	CHEMBL5476	Homo sapiens	INH	%	92.75
	15757705	CHEMBL3631724	Inhibition of ALK6 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1	Outside typical range	CHEMBL166031	=	Inhibition	%	-13.54	CHEMBL5476	Homo sapiens	INH	%	-13.54
	15757989	CHEMBL3631724	Inhibition of ALK6 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC	Outside typical range	CHEMBL3628628	=	Inhibition	%	-27.73	CHEMBL5476	Homo sapiens	INH	%	-27.73
	16604903	CHEMBL3810880	Inhibition of BMPR1b (unknown origin) at 0.1 uM by quantitative PCR	B	CC(=O)Nc1cc(Nc2cc(NC3CC3)n3ncc(C#N)c3n2)ccc1N(C)CCN		CHEMBL3103192	=	Inhibition	%	74.0	CHEMBL5476	Homo sapiens	INH	%	74.0
	16628465	CHEMBL3820168	Inhibition of human recombinant N-terminal GST-tagged ALK6 (149 amino acids end) expressed in baculovirus infected Sf9 insect cells by FRET assay	B	O=C(Nc1cc(Nc2c(Cl)cnc3c2OCO3)ccn1)C1CC1		CHEMBL3818173	=	IC50	nM	1300.0	CHEMBL5476	Homo sapiens	IC50	nM	1300.0
436744	17796707	CHEMBL3889145	Biochemical Binding Assay: Biochemical binding assays (DiscoveRx) and in vitro enzyme inhibition assays (LanthaScreen, Life Technologies) were conducted to determine the binding affinity and inhibition activities of CYT-0387 to Type-I BMPR-kinases (ALK2, ALK3, and ALK6) were conducted. Transforming growth factor beta receptor 1 (TGFBR1, ALK5) was used as a control to determine the selectivity to Type-I BMPR-kinases.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	=	IC50	nM	107.0	CHEMBL5476	Homo sapiens	IC50	nM	107.0
436744	17796708	CHEMBL3889145	Biochemical Binding Assay: Biochemical binding assays (DiscoveRx) and in vitro enzyme inhibition assays (LanthaScreen, Life Technologies) were conducted to determine the binding affinity and inhibition activities of CYT-0387 to Type-I BMPR-kinases (ALK2, ALK3, and ALK6) were conducted. Transforming growth factor beta receptor 1 (TGFBR1, ALK5) was used as a control to determine the selectivity to Type-I BMPR-kinases.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	=	Kd	nM	19.0	CHEMBL5476	Homo sapiens	Kd	nM	19.0
Inactive	17885234	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885235	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885236	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885237	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Active	17885238	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	=	Kd	nM	2013.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	2013.0
Inactive	17885239	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885240	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Active	17885241	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	2.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	2.0
Inactive	17885242	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885243	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885244	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885245	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885246	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Active	17885247	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	2161.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	2161.0
Inactive	17885248	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885249	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885250	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885251	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885252	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885253	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885254	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885255	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885256	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885257	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885258	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885259	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885260	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885261	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885262	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885263	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885264	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885265	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885266	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885267	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885268	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885269	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885270	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885271	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885272	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885273	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885274	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Active	17885275	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	=	Kd	nM	572.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	572.0
Inactive	17885276	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885277	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885278	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885279	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885280	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885281	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885282	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885283	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885284	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885285	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885286	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885287	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885288	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885289	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885290	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885291	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885292	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885293	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885294	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885295	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885296	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885297	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885298	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885299	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Active	17885300	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	=	Kd	nM	1442.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	1442.0
Active	17885301	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	=	Kd	nM	1823.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	1823.0
Inactive	17885302	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885303	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885304	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885305	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885306	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885307	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885308	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885309	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885310	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885311	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885312	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885313	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885314	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Active	17885315	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	=	Kd	nM	212.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	212.0
Inactive	17885316	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885317	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885318	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17885319	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	=	Kd	nM	29.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	29.0
Inactive	17885320	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885321	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885322	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885323	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885324	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885325	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885326	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885327	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885328	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885329	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885330	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885331	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885332	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885333	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885334	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885335	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885336	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885337	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885338	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885339	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885340	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885341	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885342	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885343	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885344	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885345	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885346	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885347	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885348	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885349	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885350	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885351	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885352	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885353	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885354	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885355	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885356	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885357	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885358	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885359	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885360	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885361	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885362	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885363	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885364	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885365	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885366	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885367	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885368	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885369	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885370	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885371	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885372	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885373	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885374	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885375	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885376	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885377	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885378	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885379	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885380	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885381	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885382	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885383	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885384	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885385	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885386	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885387	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885388	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885389	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885390	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885391	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885392	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885393	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885394	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885395	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885396	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885397	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885398	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885399	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885400	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885401	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885402	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885403	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885404	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885405	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885406	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885407	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885408	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885409	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885410	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885411	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885412	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885413	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885414	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885415	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885416	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885417	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885418	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885419	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885420	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885421	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885422	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885423	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885424	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885425	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885426	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885427	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885428	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885429	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885430	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885431	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885432	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885433	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885434	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885435	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885436	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885437	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885438	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885439	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885440	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885441	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885442	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Active	17885443	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	21.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	21.0
Inactive	17885444	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885445	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885446	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885447	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Active	17885448	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	=	Kd	nM	123.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	123.0
Inactive	17885449	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885450	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17885451	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	2302.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	2302.0
Inactive	17885452	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885453	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885454	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885455	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885456	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885457	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885458	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885459	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17885460	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	=	Kd	nM	1630.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	1630.0
Inactive	17885461	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885462	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885463	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885464	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885465	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885466	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885467	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885468	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885469	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885470	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885471	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885472	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17885473	CHEMBL3991635	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL5476	Homo sapiens	Kd apparent	nM	30000.0
	17982215	CHEMBL3998850	Inhibition of human ALK6 using casein as substrate in presence of 10 uM ATP by radiometric kinase assay	A	COc1cc(O)c2c(c1)CCC[C@H](O)[C@H](O)C(=O)CCC[C@H](C)OC2=O		CHEMBL4099337	=	IC50	nM	727.0	CHEMBL5476	Homo sapiens	IC50	nM	727.0
	17982216	CHEMBL3998850	Inhibition of human ALK6 using casein as substrate in presence of 10 uM ATP by radiometric kinase assay	A	c1ccc2c(-c3cnn4cc(-c5ccc(N6CCNCC6)cc5)cnc34)ccnc2c1		CHEMBL513147	=	IC50	nM	0.94	CHEMBL5476	Homo sapiens	IC50	nM	0.94
	17982222	CHEMBL3998856	Inhibition of human ALK6 at 10 uM using casein as substrate in presence of 200 uM ATP by radiometric kinase assay relative to control	A	COc1cc(O)c2c(c1)CCC[C@H](O)[C@H](O)C(=O)CCC[C@H](C)OC2=O		CHEMBL4099337	<	Inhibition	%	40.0	CHEMBL5476	Homo sapiens	INH	%	40.0
	18114469	CHEMBL4025025	Inhibition of wild-type human partial length BMPR1B (D178 to L502 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	100.0	CHEMBL5476	Homo sapiens	Activity	%	100.0
	18203549	CHEMBL4043836	Inhibition of wild-type human partial length BMPR1B (D178 to L502 residues) expressed in HEK293 cells assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	97.0	CHEMBL5476	Homo sapiens	Activity	%	97.0
	18253737	CHEMBL4055153	Inhibition of wild-type human partial length BMPR1B (D178 to L502 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	100.0	CHEMBL5476	Homo sapiens	Activity	%	100.0
	18253738	CHEMBL4055153	Inhibition of wild-type human partial length BMPR1B (D178 to L502 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL5476	Homo sapiens	Activity	%	100.0
	18440091	CHEMBL4156915	Binding affinity to wild-type human partial length BMPR1B (D178 to L502 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	98.0	CHEMBL5476	Homo sapiens	Activity	%	98.0
	18484531	CHEMBL4185694	Binding affinity to wild-type human partial length BMPR1B (D178 to L502 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	62.0	CHEMBL5476	Homo sapiens	Activity	%	62.0
	18485090	CHEMBL4185694	Binding affinity to wild-type human partial length BMPR1B (D178 to L502 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	100.0	CHEMBL5476	Homo sapiens	Activity	%	100.0
	18507903	CHEMBL4190859	Inhibition of recombinant human ALK6 (148 to end residues) at 1 uM using casein as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	18.0	CHEMBL5476	Homo sapiens	INH	%	18.0
	18654955	CHEMBL4230594	Binding affinity to wild-type human partial length BMPR1B (D178 to L502 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	95.0	CHEMBL5476	Homo sapiens	Activity	%	95.0
	18674984	CHEMBL4235477	Binding affinity to human ALK6 by KdELECT assay	B	Cc1nc2ccc(-c3ccnc4ccccc34)c(C)c2c(=O)[nH]1		CHEMBL4247751	=	Kd	nM	39.0	CHEMBL5476	Homo sapiens	Kd	nM	39.0
	18674985	CHEMBL4235477	Binding affinity to human ALK6 by KdELECT assay	B	O=c1c2cc(-c3ccnc4ccccc34)ccc2ncn1-c1ccc(N2CCOCC2)cc1		CHEMBL4244382	=	Kd	nM	96.0	CHEMBL5476	Homo sapiens	Kd	nM	96.0
Active	18675004	CHEMBL4235463	Inhibition of human ALK6 at 1 uM by scanEDGE assay	B	Cc1nc2ccc(-c3ccnc4ccccc34)c(C)c2c(=O)[nH]1		CHEMBL4247751		Inhibition	%		CHEMBL5476	Homo sapiens	INH		
Active	18675005	CHEMBL4235463	Inhibition of human ALK6 at 1 uM by scanEDGE assay	B	O=c1c2cc(-c3ccnc4ccccc34)ccc2ncn1-c1ccc(N2CCOCC2)cc1		CHEMBL4244382		Inhibition	%		CHEMBL5476	Homo sapiens	INH		
	18751369	CHEMBL4263986	Inhibition of ALK6 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr by TR-FRET analysis	B	CC(c1ccc(-c2cnc3c(-c4ccc(S(N)(=O)=O)c5ccccc45)cnn3c2)cc1)N1CCCC1		CHEMBL4283638	=	IC50	nM	13140.0	CHEMBL5476	Homo sapiens	IC50	nM	13140.0
	18751720	CHEMBL4264183	Binding affinity to wild-type human partial length BMPR1B (D178 to L502 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	84.0	CHEMBL5476	Homo sapiens	Activity	%	84.0
	18857854	CHEMBL4307700	Binding affinity to wild-type human partial length BMPR1B (D178 to L502 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	78.0	CHEMBL5476	Homo sapiens	Activity	%	78.0
	18892557	CHEMBL4314715	Inhibition of recombinant human ALK6 (148 to end residues) assessed as residual activity at 10 uM using casein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	103.0	CHEMBL5476	Homo sapiens	Activity	%	103.0
	18937709	CHEMBL4327584	Inhibition of human ALK6 assessed as residual activity at 1 uM using casein as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	104.14	CHEMBL5476	Homo sapiens	Activity	%	104.14
	18937710	CHEMBL4327584	Inhibition of human ALK6 assessed as residual activity at 1 uM using casein as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	104.07	CHEMBL5476	Homo sapiens	Activity	%	104.07
	18938425	CHEMBL4327945	Inhibition of human ALK6 assessed as residual activity at 100 uM using casein as substrate by [gamma-33P]-ATP assay relative to control	B	c1ccc2c(-c3cnn4cc(-c5ccc(N6CCNCC6)cc5)cnc34)ccnc2c1		CHEMBL513147	<	Activity	%	65.0	CHEMBL5476	Homo sapiens	Activity	%	65.0
Not Determined	18938795	CHEMBL4328309	Inhibition of human ALK6 using casein as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978		IC50			CHEMBL5476	Homo sapiens	IC50		
	18938796	CHEMBL4328309	Inhibition of human ALK6 using casein as substrate by [gamma-33P]-ATP assay	B	c1ccc2c(-c3cnn4cc(-c5ccc(N6CCNCC6)cc5)cnc34)ccnc2c1		CHEMBL513147	=	IC50	nM	12.7	CHEMBL5476	Homo sapiens	IC50	10'-8M	1.27
	18958671	CHEMBL4333292	Binding affinity to wild-type human partial length BMPR1B (D178 to L502 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	94.0	CHEMBL5476	Homo sapiens	Activity	%	94.0
	18964060	CHEMBL4334964	Inhibition of human ALK6 (148 to end residues) assessed as residual activity at 1 uM using casein as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	103.0	CHEMBL5476	Homo sapiens	Activity	%	103.0
	18964061	CHEMBL4334964	Inhibition of human ALK6 (148 to end residues) assessed as residual activity at 1 uM using casein as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	90.0	CHEMBL5476	Homo sapiens	Activity	%	90.0
	18971781	CHEMBL4336791	Inhibition of human ALK6 (148 to end residues) assessed as residual activity at 10 uM using casein as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	93.0	CHEMBL5476	Homo sapiens	Activity	%	93.0
Not Active	19039901	CHEMBL4351742	Inhibition of recombinant human ALK6 (148 to end residues) at 10 uM using casein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL5476	Homo sapiens	INH		
Active	19041010	CHEMBL4352271	Inhibition of human ALK6 at 10 uM using casein as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL5476	Homo sapiens	INH		
	19059471	CHEMBL4357772	Binding affinity to wild-type human partial length BMPR1B (D178 to L502 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL5476	Homo sapiens	Activity	%	100.0
	19090044	CHEMBL4365618	Inhibition of wild-type human partial length BMPR1B (D178 to L502 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	62.0	CHEMBL5476	Homo sapiens	Activity	%	62.0
	19091813	CHEMBL4366287	Inhibition of human ALK6 at 100 nM using casein as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	2.39	CHEMBL5476	Homo sapiens	INH	%	2.39
	19144612	CHEMBL4377628	Inhibition of recombinant human ALK6 (148 to end residues) at 1 uM using casein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	-1.0	CHEMBL5476	Homo sapiens	INH	%	-1.0
	19147742	CHEMBL4379138	Inhibition of human recombinant ALK6 (148 to end residues) using casein as substrate incubated for 40 mins in presence of [gamma-33P]ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL5476	Homo sapiens	IC50	uM	10.0
	19159299	CHEMBL4382403	Binding affinity to wild-type human partial length BMPR1B (D178 to L502 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	0.0	CHEMBL5476	Homo sapiens	Activity	%	0.0
	19191708	CHEMBL4389122	Inhibition of wild-type human partial length BMPR1B (D178 to L502 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	46.0	CHEMBL5476	Homo sapiens	INH	%	46.0
	19191785	CHEMBL4389599	Inhibition of wild-type human partial length BMPR1B (D178 to L502 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	63.0	CHEMBL5476	Homo sapiens	INH	%	63.0
	19199997	CHEMBL4391225	Binding affinity to wild-type human partial length BMPR1B (D178 to L502 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	25.0	CHEMBL5476	Homo sapiens	Activity	%	25.0
	19266310	CHEMBL4405260	Inhibition of wild-type human ALK6 (D178 to L502 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL5476	Homo sapiens	INH	%	50.0
Active	19271773	CHEMBL4406773	Inhibition of ALK6 (unknown origin) at 1 uM	B	COc1cc(-c2cncc(-c3ccc(N4CCN(C)CC4)cc3)c2C)cc(F)c1C(N)=O		CHEMBL4575655		Inhibition	%		CHEMBL5476	Homo sapiens	INH		
Active	19271774	CHEMBL4406773	Inhibition of ALK6 (unknown origin) at 1 uM	B	COc1cc(-c2cncc(-c3ccc(N4CCN(C(C)C)CC4)cc3)c2C)cc(F)c1C(N)=O		CHEMBL4548795		Inhibition	%		CHEMBL5476	Homo sapiens	INH		
Active	19271775	CHEMBL4406773	Inhibition of ALK6 (unknown origin) at 1 uM	B	COc1cc(-c2cncc(-c3ccc(N4C[C@H](C)N(C)[C@H](C)C4)cc3)c2C)cc(F)c1C(N)=O		CHEMBL4434717		Inhibition	%		CHEMBL5476	Homo sapiens	INH		
	19275928	CHEMBL4407931	Inhibition of recombinant human ALK6 (148 to end residues) at 1 uM using casein as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	12.0	CHEMBL5476	Homo sapiens	INH	%	12.0
	20694094	CHEMBL4626191	Inhibition of human ALK6 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(OC)c1OC		CHEMBL4517408	=	IC50	nM	68.0	CHEMBL5476	Homo sapiens	IC50	nM	68.0
	22393850	CHEMBL4667709	Binding affinity to human wild type partial length BMPR1B (D178 to L502 residues) expressed in mammalian expression system by Kinomescan method	B	COc1cc2nccc(Nc3cc(OC)c(OC)c(OC)c3)c2cc1OC		CHEMBL311959	=	Kd	nM	280.0	CHEMBL5476	Homo sapiens	Kd	nM	280.0
Active	22393895	CHEMBL4667726	Inhibition of human ALK6 at 1 uM by Kinomescan method	B	COc1cc(Nc2ccnc3cc(C#N)ccc23)cc(OC)c1OC		CHEMBL4575895		Inhibition	%		CHEMBL5476	Homo sapiens	INH		
Active	22393896	CHEMBL4667726	Inhibition of human ALK6 at 1 uM by Kinomescan method	B	COc1cc(Nc2ccnc3cc(C(F)(F)F)ccc23)cc(OC)c1OC		CHEMBL4746133		Inhibition	%		CHEMBL5476	Homo sapiens	INH		
Active	22393897	CHEMBL4667726	Inhibition of human ALK6 at 1 uM by Kinomescan method	B	COc1cc(Nc2ccnc3cc(I)ccc23)cc(OC)c1OC		CHEMBL4740155		Inhibition	%		CHEMBL5476	Homo sapiens	INH		
Active	22393898	CHEMBL4667726	Inhibition of human ALK6 at 1 uM by Kinomescan method	B	COc1cc(Nc2ccnc3cc(Br)ccc23)cc(OC)c1OC		CHEMBL4782290		Inhibition	%		CHEMBL5476	Homo sapiens	INH		
Active	22393899	CHEMBL4667726	Inhibition of human ALK6 at 1 uM by Kinomescan method	B	COc1cc(Nc2ccnc3cc(Cl)ccc23)cc(OC)c1OC		CHEMBL3925728		Inhibition	%		CHEMBL5476	Homo sapiens	INH		
	22423829	CHEMBL4674490	Inhibition of human ALK6 using casein as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	76.54	CHEMBL5476	Homo sapiens	Activity	%	76.54
	22423830	CHEMBL4674490	Inhibition of human ALK6 using casein as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	34.6	CHEMBL5476	Homo sapiens	Activity	%	34.6
	22844141	CHEMBL4721127	Inhibition of human ALK6 assessed as residual activity using casein as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	96.59	CHEMBL5476	Homo sapiens	Activity	%	96.59
	22884280	CHEMBL4727758	Inhibition of human ALK6 using casein as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(N5CCNCC5)cc4)ccn23)c2ccccc2n1		CHEMBL4740381	=	IC50	nM	18.4	CHEMBL5476	Homo sapiens	IC50	nM	18.4
	22884281	CHEMBL4727758	Inhibition of human ALK6 using casein as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(N5CCNCC5)cc4)ccn23)c2cc(F)ccc2n1		CHEMBL4788859	=	IC50	nM	29.4	CHEMBL5476	Homo sapiens	IC50	nM	29.4
	22884282	CHEMBL4727758	Inhibition of human ALK6 using casein as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(N5CCNCC5)cc4)ccn23)c2cc(F)cc(F)c2n1		CHEMBL4786529	=	IC50	nM	40.9	CHEMBL5476	Homo sapiens	IC50	nM	40.9
	22884283	CHEMBL4727758	Inhibition of human ALK6 using casein as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(C5CNCCN5)cc4)ccn23)c2ccccc2n1		CHEMBL4742906	=	IC50	nM	54.5	CHEMBL5476	Homo sapiens	IC50	nM	54.5
	22884284	CHEMBL4727758	Inhibition of human ALK6 using casein as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(C5CNCCN5)cc4)ccn23)c2cc(F)cc(F)c2n1		CHEMBL4778971	=	IC50	nM	188.0	CHEMBL5476	Homo sapiens	IC50	nM	188.0
	22886506	CHEMBL4728243	Binding affinity to BMPR1B (unknown origin) assessed as change in melting temperature at 10 uM incubated for 10 mins using SYPRO orange dye by RT-PCR-based fluorescence assay	B	CC(=O)c1cccc(-c2cnc3ccc(NCC4CC4)nn23)c1		CHEMBL200528	>	Delta Tm	degrees C	6.0	CHEMBL5476	Homo sapiens	deltaTm	degrees C	6.0
	22915620	CHEMBL4735396	Inhibition of human wild type partial length BMPR1B (D178 to L502 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	Nc1n[nH]c2cc(-c3ccc(=O)n(Cc4cccc(Cl)c4)c3)ccc12		CHEMBL4764756	=	Activity	%	19.0	CHEMBL5476	Homo sapiens	Activity	%	19.0
	22952750	CHEMBL4766687	Inhibition of human ALK6 (148 to end residues) assessed as residual activity at 10 uM using casein as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	106.0	CHEMBL5476	Homo sapiens	Activity	%	106.0
	23120117	CHEMBL4804316	Inhibition of wild-type human partial length BMPR1B (D178 to L502 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	Nc1ncc(-c2cc([N+](=O)[O-])ccc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4874241	=	Activity	%	0.75	CHEMBL5476	Homo sapiens	Activity	%	0.75
	23122243	CHEMBL4804707	Inhibition of BMPR1B in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	IC50	nM	84000.0	CHEMBL5476	Homo sapiens	IC50	uM	84.0
	23122244	CHEMBL4804707	Inhibition of BMPR1B in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4855730	=	IC50	nM	-20500.0	CHEMBL5476	Homo sapiens	IC50	uM	-20.5
	23122245	CHEMBL4804707	Inhibition of BMPR1B in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	IC50	nM	91000.0	CHEMBL5476	Homo sapiens	IC50	uM	91.0
	23122246	CHEMBL4804708	Inhibition of BMPR1B in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	75.0	CHEMBL5476	Homo sapiens	INH	%	75.0
	23122247	CHEMBL4804708	Inhibition of BMPR1B in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	0.0	CHEMBL5476	Homo sapiens	INH	%	0.0
	23122248	CHEMBL4804708	Inhibition of BMPR1B in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	>	Inhibition	%	90.0	CHEMBL5476	Homo sapiens	INH	%	90.0
	23122457	CHEMBL4804808	Inhibition of human BMPR1B assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	70.0	CHEMBL5476	Homo sapiens	Activity	%	70.0
	23123152	CHEMBL4805396	Inhibition of human BMPR1B assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	55.0	CHEMBL5476	Homo sapiens	Activity	%	55.0
	23123735	CHEMBL4805979	Inhibition of DNA-tagged human BMPR1B assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	89.0	CHEMBL5476	Homo sapiens	Activity	%	89.0
	23124394	CHEMBL4806413	Inhibition of human BMPR1B assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL5476	Homo sapiens	Activity	%	100.0
	23124395	CHEMBL4806413	Inhibition of human BMPR1B assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	62.0	CHEMBL5476	Homo sapiens	Activity	%	62.0
	23234023	CHEMBL4827602	Inhibition of wild-type human partial length BMPR1B (D178 to L502 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	O=C(O)c1ccc(-c2cnn3ccccc23)cc1C1CCCC1		CHEMBL4851925	<	Activity	%	10.0	CHEMBL5476	Homo sapiens	Activity	%	10.0
Not Active	23317292	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	87.0	CHEMBL5476	Homo sapiens	% Control	%	87.0
Not Active	23317760	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	80.0	CHEMBL5476	Homo sapiens	% Control	%	80.0
Not Active	23318433	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	77.0	CHEMBL5476	Homo sapiens	% Control	%	77.0
Not Active	23318910	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	96.0	CHEMBL5476	Homo sapiens	% Control	%	96.0
Not Active	23319550	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	59.0	CHEMBL5476	Homo sapiens	% Control	%	59.0
Not Active	23320022	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL5476	Homo sapiens	% Control	%	100.0
Not Active	23320700	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL5476	Homo sapiens	% Control	%	100.0
Not Active	23321168	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	80.0	CHEMBL5476	Homo sapiens	% Control	%	80.0
Not Active	23321798	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	61.0	CHEMBL5476	Homo sapiens	% Control	%	61.0
Not Active	23322266	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	82.0	CHEMBL5476	Homo sapiens	% Control	%	82.0
Not Active	23322955	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	71.0	CHEMBL5476	Homo sapiens	% Control	%	71.0
Not Active	23323423	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL5476	Homo sapiens	% Control	%	100.0
Not Active	23324277	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL5476	Homo sapiens	% Control	%	100.0
Not Active	23324912	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	95.0	CHEMBL5476	Homo sapiens	% Control	%	95.0
Not Active	23325380	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	78.0	CHEMBL5476	Homo sapiens	% Control	%	78.0
Not Active	23326027	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	94.0	CHEMBL5476	Homo sapiens	% Control	%	94.0
Not Active	23326495	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	81.0	CHEMBL5476	Homo sapiens	% Control	%	81.0
Not Active	23327195	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	93.0	CHEMBL5476	Homo sapiens	% Control	%	93.0
Not Active	23327663	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	85.0	CHEMBL5476	Homo sapiens	% Control	%	85.0
Not Active	23328250	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	77.0	CHEMBL5476	Homo sapiens	% Control	%	77.0
Not Active	23328718	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	82.0	CHEMBL5476	Homo sapiens	% Control	%	82.0
Not Active	23329244	CHEMBL4880951	ALK6(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	102.0	CHEMBL5476	Homo sapiens	% residual kinase activity	%	102.0
Not Active	23329664	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL5476	Homo sapiens	% Control	%	100.0
Not Active	23330132	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	93.0	CHEMBL5476	Homo sapiens	% Control	%	93.0
Not Active	23330888	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	82.0	CHEMBL5476	Homo sapiens	% Control	%	82.0
Not Active	23331356	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL5476	Homo sapiens	% Control	%	100.0
Not Active	23331943	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	72.3	CHEMBL5476	Homo sapiens	% Control	%	72.3
Not Active	23332411	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL5476	Homo sapiens	% Control	%	100.0
Not Active	23333127	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	74.2	CHEMBL5476	Homo sapiens	% Control	%	74.2
Not Active	23333766	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	83.0	CHEMBL5476	Homo sapiens	% Control	%	83.0
Not Active	23334234	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL5476	Homo sapiens	% Control	%	100.0
Not Active	23335213	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	68.0	CHEMBL5476	Homo sapiens	% Control	%	68.0
Not Active	23335681	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	86.0	CHEMBL5476	Homo sapiens	% Control	%	86.0
Not Active	23336308	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	95.0	CHEMBL5476	Homo sapiens	% Control	%	95.0
Not Active	23336776	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL5476	Homo sapiens	% Control	%	100.0
Not Active	23337857	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	76.0	CHEMBL5476	Homo sapiens	% Control	%	76.0
Not Active	23338325	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	99.0	CHEMBL5476	Homo sapiens	% Control	%	99.0
Not Active	23338937	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL5476	Homo sapiens	% Control	%	100.0
Not Active	23339405	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	55.0	CHEMBL5476	Homo sapiens	% Control	%	55.0
Not Active	23340042	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	82.0	CHEMBL5476	Homo sapiens	% Control	%	82.0
Not Active	23340510	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL5476	Homo sapiens	% Control	%	100.0
Not Active	23341167	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL5476	Homo sapiens	% Control	%	100.0
Not Active	23341635	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	89.0	CHEMBL5476	Homo sapiens	% Control	%	89.0
Not Active	23342251	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	91.0	CHEMBL5476	Homo sapiens	% Control	%	91.0
Not Active	23342719	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL5476	Homo sapiens	% Control	%	100.0
Not Active	23343349	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	96.0	CHEMBL5476	Homo sapiens	% Control	%	96.0
Not Active	23343817	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	88.0	CHEMBL5476	Homo sapiens	% Control	%	88.0
Not Active	23344455	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	71.0	CHEMBL5476	Homo sapiens	% Control	%	71.0
Not Active	23345028	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	77.0	CHEMBL5476	Homo sapiens	% Control	%	77.0
Not Active	23345496	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	95.0	CHEMBL5476	Homo sapiens	% Control	%	95.0
Not Active	23346073	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL5476	Homo sapiens	% Control	%	100.0
Not Active	23346542	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	92.3	CHEMBL5476	Homo sapiens	% Control	%	92.3
Not Active	23347152	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	69.4	CHEMBL5476	Homo sapiens	% Control	%	69.4
Not Active	23347633	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL5476	Homo sapiens	% Control	%	100.0
Not Active	23348212	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL5476	Homo sapiens	% Control	%	100.0
Not Active	23348680	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL5476	Homo sapiens	% Control	%	100.0
Not Active	23349267	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL5476	Homo sapiens	% Control	%	100.0
Not Active	23349885	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL5476	Homo sapiens	% Control	%	100.0
Not Active	23350353	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL5476	Homo sapiens	% Control	%	100.0
Not Active	23350958	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL5476	Homo sapiens	% Control	%	100.0
Not Active	23351426	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL5476	Homo sapiens	% Control	%	100.0
Not Active	23352450	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	81.0	CHEMBL5476	Homo sapiens	% Control	%	81.0
Not Active	23352918	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	77.0	CHEMBL5476	Homo sapiens	% Control	%	77.0
Not Active	23353800	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL5476	Homo sapiens	% Control	%	100.0
Not Active	23354268	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL5476	Homo sapiens	% Control	%	100.0
Not Active	23355000	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL5476	Homo sapiens	% Control	%	100.0
Not Active	23355468	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL5476	Homo sapiens	% Control	%	100.0
Not Active	23356104	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	96.0	CHEMBL5476	Homo sapiens	% Control	%	96.0
Not Active	23356572	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	83.0	CHEMBL5476	Homo sapiens	% Control	%	83.0
Not Active	23357181	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	95.0	CHEMBL5476	Homo sapiens	% Control	%	95.0
Not Active	23357828	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	88.0	CHEMBL5476	Homo sapiens	% Control	%	88.0
Not Active	23358296	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	91.0	CHEMBL5476	Homo sapiens	% Control	%	91.0
Not Active	23358882	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	64.5	CHEMBL5476	Homo sapiens	% Control	%	64.5
Not Active	23359480	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	94.0	CHEMBL5476	Homo sapiens	% Control	%	94.0
Not Active	23359948	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	89.0	CHEMBL5476	Homo sapiens	% Control	%	89.0
Not Active	23360533	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	83.0	CHEMBL5476	Homo sapiens	% Control	%	83.0
Not Active	23361001	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL5476	Homo sapiens	% Control	%	100.0
Not Active	23361574	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	60.0	CHEMBL5476	Homo sapiens	% Control	%	60.0
Not Active	23362110	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL5476	Homo sapiens	% Control	%	100.0
Not Active	23362578	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	94.0	CHEMBL5476	Homo sapiens	% Control	%	94.0
Not Active	23364220	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	92.0	CHEMBL5476	Homo sapiens	% Control	%	92.0
Not Active	23364688	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	89.0	CHEMBL5476	Homo sapiens	% Control	%	89.0
Not Active	23365427	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	84.0	CHEMBL5476	Homo sapiens	% Control	%	84.0
Not Active	23365970	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	92.0	CHEMBL5476	Homo sapiens	% Control	%	92.0
Not Active	23366560	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL5476	Homo sapiens	% Control	%	100.0
Not Active	23367028	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	92.0	CHEMBL5476	Homo sapiens	% Control	%	92.0
Not Active	23367906	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	98.0	CHEMBL5476	Homo sapiens	% Control	%	98.0
Not Active	23368374	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	87.0	CHEMBL5476	Homo sapiens	% Control	%	87.0
Not Active	23368973	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	86.0	CHEMBL5476	Homo sapiens	% Control	%	86.0
Not Active	23369441	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	59.0	CHEMBL5476	Homo sapiens	% Control	%	59.0
Not Active	23369969	CHEMBL4884216	ALK6(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	99.0	CHEMBL5476	Homo sapiens	% residual kinase activity	%	99.0
Not Active	23370409	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	96.0	CHEMBL5476	Homo sapiens	% Control	%	96.0
Not Active	23370877	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	91.0	CHEMBL5476	Homo sapiens	% Control	%	91.0
Not Active	23371686	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL5476	Homo sapiens	% Control	%	100.0
Not Active	23372154	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	91.0	CHEMBL5476	Homo sapiens	% Control	%	91.0
	23372667	CHEMBL4884632	BMPR1B(BM1BLGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL5476	Homo sapiens	pIC50		6.0
	23373076	CHEMBL4884923	BMPR1B(BM1BLGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL5476	Homo sapiens	pIC50		6.0
	23373437	CHEMBL4885214	BMPR1B(BM1BLGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL5476	Homo sapiens	pIC50		6.0
Not Active	23375581	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	87.0	CHEMBL5476	Homo sapiens	% Control	%	87.0
Not Active	23376049	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL5476	Homo sapiens	% Control	%	100.0
Not Active	23376627	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	75.0	CHEMBL5476	Homo sapiens	% Control	%	75.0
Not Active	23377096	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	71.0	CHEMBL5476	Homo sapiens	% Control	%	71.0
Not Active	23377954	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	82.0	CHEMBL5476	Homo sapiens	% Control	%	82.0
Not Active	23378422	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	100.0	CHEMBL5476	Homo sapiens	% Control	%	100.0
Not Active	23379589	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	67.0	CHEMBL5476	Homo sapiens	% Control	%	67.0
Not Active	23380057	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	95.0	CHEMBL5476	Homo sapiens	% Control	%	95.0
Not Active	23380751	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	95.0	CHEMBL5476	Homo sapiens	% Control	%	95.0
Not Active	23381399	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	99.0	CHEMBL5476	Homo sapiens	% Control	%	99.0
Not Active	23381867	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL5476	Homo sapiens	% Control	%	100.0
Not Active	23382491	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	65.0	CHEMBL5476	Homo sapiens	% Control	%	65.0
Active	23382959	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	3.6	CHEMBL5476	Homo sapiens	% Control	%	3.6
Not Active	23383581	CHEMBL4887241	BMPR1B (ALK6) Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	74.0	CHEMBL5476	Homo sapiens	% Ctrl	%	74.0
Not Active	23384176	CHEMBL4887771	ALK6(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O	Outside typical range	CHEMBL4802045		Inhibition	%	-11.34	CHEMBL5476	Homo sapiens	% inhibition	%	-11.34
Not Active	23384874	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	100.0	CHEMBL5476	Homo sapiens	% Control	%	100.0
Not Active	23385341	CHEMBL4879598	KinomeScan assay: inhibition of BMPR1B	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	100.0	CHEMBL5476	Homo sapiens	% Control	%	100.0
